TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bergentoft Pharma Consulting AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
2,054
|
1,176
|
617 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,266
|
811
|
359 |
| EBITDA |
1,266
|
811
|
359 |
| Total assets |
2,938
|
1,699
|
1,040 |
| Current assets |
1,938
|
1,699
|
1,040 |
| Current liabilities |
766
|
409
|
211 |
| Equity capital |
2,018
|
1,202
|
752 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
68.7%
|
70.7%
|
72.3% |
| Turnover per employee |
2,054
|
1,176
|
617 |
| Profit as a percentage of turnover |
61.6%
|
69.0%
|
58.2% |
| Return on assets (ROA) |
43.1%
|
47.7%
|
34.5% |
| Current ratio |
253.0%
|
415.4%
|
492.9% |
| Return on equity (ROE) |
62.7%
|
67.5%
|
47.7% |
| Change turnover |
878
|
559
|
-358 |
| Change turnover % |
75%
|
91%
|
-37% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.